Overview

Dexmedetomidine Versus Magnesium Infusion in Reducing Agitations in Pediatric Patients Undergoing Adenotonsillectomy

Status:
Active, not recruiting

Trial end date:
2022-12-07

Target enrollment:

Participant gender:

Summary

The aim of this study is evaluating the efficacy and safety of dexmedetomidine versus Magnesium for reducing emergence agitation after adenotonsillectomy in children. Secondary outcome is to reduce child needs for analgesics and to reduce their dose.

Phase:

N/A

Details

Lead Sponsor:

Ain Shams University

Treatments:

Dexmedetomidine
Magnesium Sulfate